Awarded contract

Ono type DX Breast Recurrence Score Test

Details

Value
£337,500
Duration
2 years
Topic
Pathology services
Published
26 October 2026

Tender description

Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.

Timeline

  1. Completed: Award date1 July 2026
  2. Completed: Award published26 October 2026
    Current notice
  3. Next: Contract expiry date30 June 2028in 2 years

About the buyer

Leeds Teaching Hospitals NHS Trust is an NHS trust with its own procurement team of more than 100 staff, covering contracting, logistics and supplier relationships. NHS Supply Chain supplies goods and services through its national contracts. Procurement handles all non-pay spend across the Trust, excluding pharmacy. The Trust buys jointly with five Yorkshire trusts through the West Yorkshire Association of Acute Trusts.

Over the past 5 years, most of Leeds Teaching Hospitals NHS Trust's contract awards have been in medical equipment and pharmaceuticals, repair and maintenance and construction work.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?

This one's been awarded. Find the next before it's published.

Get a free pre-tender lead
Save this contract

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Related topics

Topics related to Ono type DX Breast Recurrence Score Test, ranked by notice volume.

View all topics
TopicCountValue
  1. 11,649
    £1.0tn
  2. 28,038
    £1.7tn

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.